Baron Asset Fund Comments on West Pharmaceutical Services

- By Holly LaFon

Shares of West Pharmaceutical Services, Inc. (WST), a manufacturer of packaging components and delivery devices for injectable drugs, gained after reporting impressive quarterly financial results. Management provided solid guidance for 2017 and reaffirmed its goals for strong growth through 2020. We continue to believe that West can double its earnings over the next five years, driven by sales of higher margin packaging components and proprietary products to the pharmaceutical and biotechnology industries.

• Warning! GuruFocus has detected 7 Warning Signs with FRC. Click here to check it out.

• WST 15-Year Financial Data

• The intrinsic value of WST

• Peter Lynch Chart of WST

From Barron Asset Fund fourth quarter 2016 commentary.

This article first appeared on GuruFocus.

• Warning! GuruFocus has detected 7 Warning Signs with FRC. Click here to check it out.

• WST 15-Year Financial Data

• The intrinsic value of WST

• Peter Lynch Chart of WST